Product Information
EZETIMIBE-SIMVASTATIN 10-10 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3283 per EA under NDC 68462032130. Its NADAC has been published 334 times since Apr 1, 2020.
FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 10 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208699FDA Approved
6/27/2019
TE Code
AB
On Market Since
6/27/2019
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has been published 334 times since Apr 1, 2020, and over the history we have for it it has declined 79.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3283 per EA |
|---|---|
| All-time high | $1.7793 (Sep 16, 2020) |
| All-time low | $0.2356 (Apr 19, 2023) |
| 52-week high | $0.3810 |
| 52-week low | $0.2639 |
| Median price | $0.4520 |
| Average price | $0.6251 |
| Largest weekly change | +75.7% (May 17, 2023) |
| Weeks tracked | 334 |
| Tracking since | Apr 1, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-10 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3283 per EA (NDC 68462032130), effective Aug 19, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-10 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has declined 79.0%. It has been tracked across 334 weekly CMS publications since Apr 1, 2020.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-10 MG?
Since Apr 1, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has ranged from a low of $0.2356 (Apr 19, 2023) to a high of $1.7793 (Sep 16, 2020), with a median of $0.4520 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-10 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-10 MG, is $0.3188 per EA — about 3% below EZETIMIBE-SIMVASTATIN 10-10 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-10 MG?
EZETIMIBE-SIMVASTATIN 10-10 MG (NDC 68462032130) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.